Aggressive administration of recombinant oncotoxin AR209 (anti-ErB-2) in athymic nude mice implanted with orthotopic human non-small cell lung tumours

Keyphrases

• Residual Tumor 100%
• Tumor 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Recombinant 100%
• Athymic nude Mice 100%
• Lung Tumor 100%
• ErbB2 100%
• Treatment Schedule 100%
• Lung Cancer 50%
• Intravenous Injection 50%
• Tumor Size 50%
• Cell Membrane 50%
• Surgical Resection 50%
• Tumor Xenograft 50%
• Aggressive Treatment 50%
• Public Health Risk 50%
• Recurring 50%
• Subcutaneous Injection 50%
• Microscopic Analysis 50%
• Conventional Chemotherapy 50%
• Necropsy 50%
• Inappropriate Treatment 50%
• Drug Treatment 50%
• Salvage Therapy 50%
• Traditional Therapy 50%
• Orthotopic Lung Cancer Model 50%
• Pseudomonas Exotoxin A 50%
• Antibody Domain 50%
• Single-chain Antibody 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Nude Mouse 100%
• Lung Tumor 100%
• Lung Cancer 50%
• Chemotherapy 50%
• Pharmacotherapy 50%
• Non Small Cell Lung Cancer 50%
• Subcutaneous Injection 50%
• Pseudomonas Exotoxin 50%
• Epidermal Growth Factor Receptor 2 50%
• Single Chain Fragment Variable Antibody 50%